re: Ann: Appendix 4E and Audited Annual Finan... The Company also aims to add enterprise value through internal discovery programmes and enhancements to its intellectual property portfolio, which increases potential for further licensing deals and may also make the Company an attractive merger or acquisition candidate.
- Forums
- ASX - By Stock
- PYC
- Ann: Appendix 4E and Audited Annual Financial Sta
PYC
pyc therapeutics limited
Add to My Watchlist
3.03%
!
$1.28

Ann: Appendix 4E and Audited Annual Financial Sta, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.28 |
Change
-0.040(3.03%) |
Mkt cap ! $746.5M |
Open | High | Low | Value | Volume |
$1.32 | $1.35 | $1.28 | $764.7K | 579.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4000 | $1.28 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.30 | 40248 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4000 | 1.275 |
1 | 13987 | 1.265 |
2 | 16060 | 1.260 |
1 | 12000 | 1.255 |
2 | 2800 | 1.250 |
Price($) | Vol. | No. |
---|---|---|
1.300 | 40248 | 3 |
1.330 | 5000 | 1 |
1.345 | 53113 | 2 |
1.350 | 22000 | 2 |
1.360 | 5958 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online